4//SEC Filing
ALEXION PHARMACEUTICALS INC 4
Accession 0000899866-16-000266
CIK 0000899866operating
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 6:32 PM ET
Size
8.9 KB
Accession
0000899866-16-000266
Insider Transaction Report
Form 4
Carmichael Clare
SVP, Chief HR Officer
Transactions
- Award
Common Stock, par value $.0001 per share
2016-02-26+7,000→ 41,054 total - Award
Option to Purchase Common Stock
2016-02-26$140.16/sh+31,000$4,344,960→ 31,000 totalExercise: $140.16From: 2017-02-26Exp: 2026-02-26→ Common Stock, par value $.0001 per share (31,000 underlying) - Sale
Common Stock, par value $.0001 per share
2016-02-29$138.91/sh−1,312$182,250→ 39,742 total
Footnotes (4)
- [F1]Award of Restricted Stock Units under the 2004 Incentive Plan. 25% vests on each anniversary of the grant date.
- [F2]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $138.00 - $138.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F4]25% vests on the first anniversary of the grant date and 1/16 every three months thereafter.
Documents
Issuer
ALEXION PHARMACEUTICALS INC
CIK 0000899866
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000899866
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 6:32 PM ET
- Size
- 8.9 KB